Prevalence and Risk Factors of Osteoporosis in Patients with Type 2 Diabetes Mellitus in Nanchang (China): A Retrospective Cohort Study

References

• Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes. 2021;13(04):315–409.
   Google Scholar
• Chinese Medical Association. Guideline for primary care of primary osteoporosis (2019). Chin J Gen Pract. 2020;19(04):304–315.
   Google Scholar
• Jiang N, Xia W. Assessment of bone quality in patients with diabetes mellitus. Osteoporos Int. 2018;29(8):1721–1736.
   PubMed Web of Science ®Google Scholar
• Poiana C, Capatina C. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom. 2017;20(3):432–443.
   PubMed Web of Science ®Google Scholar
• Thong EP, Herath M, Weber DR, et al. Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: a systematic review and meta-analysis. Clin Endocrinol. 2018;89(3):314–323.
   Web of Science ®Google Scholar
• Wang H, Ba Y, Xing Q, Du JL. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9(1):e024067.
   PubMed Web of Science ®Google Scholar
• Sato M, Ye W, Sugihara T, Isaka Y. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. BMC Musculoskelet Disord. 2016;17(1):489.
   PubMed Web of Science ®Google Scholar
• Heilmeier U, Hackl M, Schroeder F, et al. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus. Bone. 2022;158:116308.
   Web of Science ®Google Scholar
• Kara Z, Güneş M, Bolayırlı İM, et al. The effects of diabetic polyneuropathy and autonomic neuropathy on bone turnover. Metab Syndr Relat Disord. 2022;20:11–19.
   Google Scholar
• Zhang Z, Jin X, Xia W. Key points of diagnosis and treatment guidelines for primary osteoporosis (2017 Edition). Chin J Osteopor Bone Mineral Res. 2017;5:8.
   Google Scholar
• Jawhar DS, Hassan NA, Shamssain MH. Dual-energy x-ray absorptiometry scan (DXA) findings in diabetic and non-diabetic female: a retrospective cohort study. Med J Malaysia. 2020;75(1):47–51.
   Google Scholar
• Si Y, Wang C, Guo Y, Xu G, Ma Y. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta-analysis. Iran J Public Health. 2019;48(7):1203–1214.
   PubMed Web of Science ®Google Scholar
• Palermo A, Tuccinardi D, Defeudis G, et al. BMI and BMD: the Potential Interplay between Obesity and Bone Fragility. Int J Environ Res Public Health. 2016;13(6):544.
   Web of Science ®Google Scholar
• Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16(1):1039.
   PubMed Web of Science ®Google Scholar
• Tian L, Yang R, Wei L, et al. Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: a cross-sectional study in Gansu province, Northwestern of China. Medicine. 2017;96(43):e8294.
   PubMed Web of Science ®Google Scholar
• Cui L, Chen L, Xia W, et al. Vertebral fracture in postmenopausal Chinese women: a population-based study. Osteoporos Int. 2017;28(9):2583–2590.
   Web of Science ®Google Scholar
• Jepsen KJ, Schlecht SH. Biomechanical mechanisms: resolving the apparent conundrum of why individuals with type II diabetes show increased fracture incidence despite having normal BMD. J Bone Miner Res. 2014;29(4):784–786.
   Web of Science ®Google Scholar
• Groenendijk I, Chan R, Woo J, et al. A combined nutrition and exercise intervention influences serum vitamin B-12 and 25-hydroxyvitamin D and bone turnover of healthy Chinese middle-aged and older adults. J Nutr. 2020;150(8):2112–2119.
   Web of Science ®Google Scholar
• Fu Y, Xu Y, Chen S, Ouyang Y, Sun G. MiR-151a-3p promotes postmenopausal osteoporosis by targeting SOCS5 and activating JAK2/STAT3 signaling. Rejuvenation Res. 2020;23(4):313–323.
   PubMed Web of Science ®Google Scholar
• He Y, Chen D, Guo Q, Shi P, You C, Feng Y. MicroRNA-151a-3p functions in the regulation of osteoclast differentiation: significance to postmenopausal osteoporosis. Clin Interv Aging. 2021;16:1357–1366.
   Web of Science ®Google Scholar
• Conway BN, Long DM, Figaro MK, May ME. Glycemic control and fracture risk in elderly patients with diabetes. Diabetes Res Clin Pract. 2016;115:47–53.
   PubMed Web of Science ®Google Scholar
• Maycas M, Portolés MT, Matesanz MC, et al. High glucose alters the secretome of mechanically stimulated osteocyte-like cells affecting osteoclast precursor recruitment and differentiation. J Cell Physiol. 2017;232(12):3611–3621.
   Web of Science ®Google Scholar
• Głogowska-Szeląg J, Kos-Kudła B, Marek B, Nowak M, Siemińska L. Assessment of selected adipocytokines in obese women with postmenopausal osteoporosis. Endokrynol Pol. 2019;70(6):478–483.
   Web of Science ®Google Scholar
• Johansson H, Kanis JA, Odén A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014;29(1):223–233.
   PubMed Web of Science ®Google Scholar
• Ahmed LA, Schirmer H, Berntsen GK, Fønnebø V, Joakimsen RM. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int. 2006;17(3):426–432.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li Y, Zhang M, Qi L, Tang Y. Blood lipid levels in patients with osteopenia and osteoporosis: asystematic review and meta-analysis. J Bone Miner Metab. 2021;39(3):510–520.
   PubMed Web of Science ®Google Scholar
• Kha HT, Basseri B, Shouhed D, et al. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J Bone Miner Res. 2004;19(5):830–840.
   Web of Science ®Google Scholar
• Avogaro A, Fadini GP. Microvascular complications in diabetes: a growing concern for cardiologists. Int J Cardiol. 2019;15(291):29–35.
   Web of Science ®Google Scholar
• Shanbhogue VV, Hansen S, Frost M, et al. Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. Eur J Endocrinol. 2016;174(2):115–124.
   Web of Science ®Google Scholar
• Chen H, Liu W, Wu X, Gou M, Shen J, Wang H. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways. Int Immunopharmacol. 2017;52:143–149.
   Web of Science ®Google Scholar
• Sanguineti R, Puddu A, Mach F, Montecucco F, Viviani GL. Advanced glycation end products play adverse proinflammatory activities in osteoporosis. Mediators Inflamm. 2014;2014:975872.
   Web of Science ®Google Scholar
• Beeve AT, Brazill JM, Scheller EL. Peripheral neuropathy as a component of skeletal disease in diabetes. Curr Osteoporos Rep. 2019;17(5):256–269.
   Web of Science ®Google Scholar
• Kluding PM, Bareiss SK, Hastings M, Marcus RL, Sinacore DR, Mueller MJ. Physical training and activity in people with diabetic peripheral neuropathy: paradigm shift. Phys Ther. 2017;97(1):31–43.
   Web of Science ®Google Scholar
• Börekci E, Kara A, Kılıç M, et al. The increase of neuropathic symptoms in diabetic patients is related with osteopenia. Neurol Sci. 2021;42(7):2873–2880.
   Web of Science ®Google Scholar